How a Bone-Building Drug is Revolutionizing Tooth Movement
The secret to faster orthodontics might lie in an unexpected medicine already used to treat osteoporosis.
For millions undergoing orthodontic treatment, the process is a test of patience. Traditional braces or aligners slowly guide teeth into their new positions over months or even years, a pace dictated by the body's own biology. But what if this process could be safely accelerated?
Emerging research is exploring a fascinating possibility: using a medication called teriparatide to influence the very bone remodeling processes that underpin tooth movement. This isn't a new, experimental drug; it's already an established treatment for osteoporosis. Scientists are now investigating its potential to not only speed up orthodontic treatment but also to protect teeth from an unwanted side effect of straightening them: root resorption.
To understand how teriparatide could work, we must first look at what happens when teeth move. Orthodontic treatment is essentially a carefully controlled injury.
When a constant, gentle force is applied to a tooth, one side of the socket experiences pressure, while the opposite side experiences tension.
On the pressure side, specialized cells called osteoclasts break down bone. On the tension side, osteoblasts build new bone 1 .
The speed of this continuous cycle of bone resorption and formation determines how quickly a tooth can move. Teriparatide may accelerate this process.
The promise of teriparatide lies in its potential to directly influence and accelerate the fundamental process of bone remodeling that controls tooth movement speed.
Teriparatide is a synthetic version of a portion of the human parathyroid hormone (PTH). It is clinically known as PTH (1-34) and is used as a long-term treatment for osteoporosis, a condition characterized by weakened bones and reduced bone density 1 6 .
Its action seems almost paradoxical. While continuously high levels of PTH can lead to bone loss, the intermittent, low-dose administration of teriparatide has a powerful anabolic effect—meaning it stimulates the formation of new bone 1 2 . It works by boosting the activity and longevity of osteoblasts, the body's bone-building cells, thereby increasing bone density and accelerating bone turnover 1 .
Anabolic Effect: Stimulates bone formation by activating osteoblasts
Intermittent, low-dose teriparatide is administered
Teriparatide stimulates osteoblasts (bone-building cells)
Increased bone density and accelerated bone turnover occurs
Enhanced bone remodeling potentially accelerates orthodontic tooth movement
In 2016, a systematic review set out to consolidate the scientific evidence on this very topic. Titled "The influence of teriparatide in induced tooth movement," this research rigorously analyzed all available experimental studies to answer a critical question: Does teriparatide administration optimally influence induced tooth movement? 1 3
| Aspect | Finding | Significance |
|---|---|---|
| Overall Effect | Potential acceleration of tooth movement | Suggests teriparatide can actively influence the pace of orthodontics |
| Key Factor | Method of administration is critical | Local application is more effective than systemic injections |
| Delivery Innovation | Dilution in methyl cellulose (MC) gel | Extends release time, allowing for lower, safer drug concentrations |
| Evidence Base | Based on 3 high-quality rat studies | Findings are robust but preclinical; human trials are the next step |
To truly appreciate how this research is conducted, let's examine a pivotal study that investigated another crucial aspect: teriparatide's effect on root resorption.
This 2023 study used female Wistar rats to simulate a clinical scenario common in older adults: orthodontic treatment in the presence of osteoporosis 8 .
Inducing Osteoporosis via ovariectomy (OVX)
Treatment with teriparatide or placebo
Applying orthodontic force with coil springs
Analysis using micro-CT scanning
The micro-CT results revealed a compelling story:
This experiment provides powerful evidence that teriparatide's anabolic action does more than just speed up tooth movement; it also appears to have a protective effect, enhancing the body's ability to repair the minor root damage inherent to the orthodontic process. This suggests a dual benefit: faster treatment and healthier teeth upon completion.
| Group | Day 7 | Day 14 | Day 21 |
|---|---|---|---|
| Control (Healthy) | Mild resorption | Moderate resorption | Moderate resorption |
| OVX (Osteoporotic) | Mild resorption | Significant resorption | Severe resorption |
| OVX + Teriparatide | Mild resorption | Moderate resorption | Significantly reduced resorption |
| Research Tool | Function in the Experiment |
|---|---|
| Teriparatide (PTH 1-34) | The primary intervention; an anabolic agent to stimulate bone turnover. |
| Ovariectomized (OVX) Rat Model | A well-established preclinical model for studying postmenopausal osteoporosis. |
| Closed-Coil Spring | Applies a constant, measurable orthodontic force to induce tooth movement. |
| Micro-CT Scanner | Provides high-resolution 3D images to quantitatively measure tooth movement and root resorption lacunae. |
| Methyl Cellulose (MC) Gel | A delivery vehicle that allows for sustained, local release of teriparatide. |
The potential applications of teriparatide in dentistry extend beyond orthodontics. Robust research has shown its remarkable effectiveness in treating Medication-Related Osteonecrosis of the Jaw (MRONJ), a severe condition where the jawbone fails to heal after tooth extraction or trauma in patients on certain bone-strengthening drugs 4 7 9 .
Clinical studies have demonstrated that both daily and weekly administration of teriparatide can significantly improve healing outcomes, leading to faster resolution of MRONJ and a higher likelihood of complete recovery 4 7 . This success underscores the drug's powerful capacity to stimulate bone regeneration and healing in the craniofacial region, reinforcing its potential utility in orthodontics.
The systematic review and subsequent preclinical studies paint a promising picture. Teriparatide, through its ability to stimulate bone remodeling, holds the potential to accelerate orthodontic tooth movement and, perhaps even more importantly, reduce the risk of root resorption, a common undesirable side effect of treatment.
However, it is crucial to remember that the current evidence is primarily from animal studies. Translating these findings into a safe and effective clinical protocol for humans will require extensive further research, including randomized controlled trials to determine optimal dosing, timing, and delivery methods.
While your orthodontist won't be prescribing teriparatide injections just yet, this research opens a fascinating window into a future where orthodontic treatment could be not only faster but also safer, leveraging our growing understanding of bone biology to achieve the perfect smile.
References to be added manually here.